ÂÜÀòÂÒÂ×

Michael Goldberg is Executive Chairman of Nodality, Inc. During a career spanning 30 years, he has been a company founder, CEO, board member and venture capitalist. Michael joined the life science industry in 1981 and participated in the commercialization of the first generation of recombinant DNA, monoclonal antibody and PCR technology. Michael joined Nodality's board to help guide the commercialization of SCNP (Single Cell Network Profiling) which he thinks has similar disruptive potential for drug development and clinical medicine.